Project Grant R35GM162563
- Federal Grant Award Summary The University of Tennessee received a $406,112 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 5, 2026, with completion targeted for February 28, 2031. The award funds pioneering research to develop and advance mass spectrometry (MS)-based footprinting techniques designed to reveal the native higher-order structures and functional...
- Federal Grant Award Summary The University of Tennessee has been awarded $436,547 under the Biomedical Research and Research Training program (CFDA 93.859), administered by the National Institute of General Medical Sciences (NIGMS), for a two-year project period running from September 1, 2025, through August 31, 2027. The project aims to develop and validate a model for determining fluid bilayer structure from cryo-electron microscopy (cryo-EM) images of biomembranes. The research will deliver...
- Federal Grant Award Summary The University of Tennessee received a $1.92 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded August 1, 2025, with completion targeted for July 31, 2029. This grant funds fundamental biomedical research investigating microbial metabolic interactions in polymicrobial environments, with a specific focus on chronic wounds as a model system. The...
- Federal Project Grant Award Summary The University of Texas at Arlington received a $360,188 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award supports a five-year research initiative focused on developing and applying chemical proteomics strategies to quantify inflammatory protein networks and post-translational modifications...
- Federal Grant Award Summary The University of Tennessee Health Science Center (UTHSC) received a $782,795 Project Grant award dated June 17, 2025, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research project, "Regulation of Chlamydial Divisome Assembly," focuses on investigating the mechanisms underlying cell division in Chlamydia trachomatis, the leading bacterial cause of sexually...
- Federal Grant Award Summary The University of Utah received a $423,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 5, 2025, through July 31, 2030. This five-year research initiative delivers fundamental scientific investigation into the mechanisms of compartmentalized signaling in electrically excitable cells, specifically examining how electrical signals in neurons...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded UC San Diego a $249,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) for the period September 1, 2025 through August 31, 2028. This award supports fundamental research to advance understanding of how biophysical cues shape macrophage and T-cell functions in the context of inflammation and cancer. The research deliverables include the development and...
- Federal Grant Award Summary Award Overview Vanderbilt University received a $877,872 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 1, 2025, with completion targeted for March 31, 2029. The project focuses on developing pan- and phospho-specific nanobodies for investigating mitogen-activated protein kinase (MAPK) and protein phosphatase 2A (PP2A) signaling pathways. This...
- Federal Grant Award Summary The University of Utah received a $423,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2025 through June 30, 2030. This Maximizing Investigators' Research Award (MIRA/R35) consolidates multiple research initiatives into a comprehensive investigation of post-translational modification (PTM)-driven cell signaling mechanisms with...
- Federal Grant Award Summary The University of Connecticut Health Center received a $423,352 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 18, 2026 through February 28, 2031. This award funds fundamental biomedical research investigating dead cell-phagocyte interactions at the phagosomal interface to decode death-associated responses. The research employs a cutting-edge...
The University of Tennessee received a $413,069 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, through February 28, 2031. This award supports fundamental biomedical research investigating the spatial regulation of plasma membrane signaling in immune cells, specifically focusing on how T cell receptor (TCR) signaling complexes are assembled and regulated within heterogeneous membrane microenvironments. The research employs super-resolution localization microscopy (SMLM) to visualize and quantitatively measure the organization of signaling molecules and receptors at sub-micron length scales—dimensions previously inaccessible to conventional microscopy techniques. The project deliverables include advanced fluorescence imaging studies and mechanistic insights into receptor triggering and microcluster assembly during immune cell activation. Research findings will contribute to fundamental understanding of signal transduction processes and may inform approaches to address defects in immune signaling associated with autoimmune disease and immunodeficiency. The research will be conducted at the University of Tennessee's facility in Knoxville, Tennessee, with performance spanning the five-year award period.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $413.1k | 3/25/26 |